Conclusions The present updated meta-analysis of randomised clinical trials demonstrated that the use of semaglutide was associated with a marked anti-inflammatory effect
Pharmacist Post Test (for viewing only) Ketogenic Diet: Fad Weight Loss or True Medical Benefits
Although the convergence across studies was still too low for GLP-1, we identified an overlap of reported activations with the effects of ghrelin as well as potential phases-dependent effects that warrant further emphasis in future studies
Lilly intends to submit registration package to regulatory authorities by the end of 2021 News provided by Eli Lilly & Company May 20, 2021, 06:45 ET INDIANAPOLIS, May 20, 2021 /PRNewswire/ -- Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses in adults with type 2 diabetes who have increased cardiovascular (CV) risk compared to titrated insulin glargine in topline results from Eli Lilly and Company's (NYSE: LLY) SURPASS-4 clinical trial
Saxenda may still have a role for specific patients whose insurance covers it preferentially, who have had previous success with liraglutide, or who have particular reasons to prefer that medication
So perhaps the pessimist in me thinks this might just be another case of the medical system devaluing women.
